4. Progression-free survival (PFS) of patients with deleterious germline BRCA1/2 (gBRCA) mutations according to treatment group. mPFS, median PFS.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.